A critical advance in cancer investigation is arising with the use of mini-antibodies to reactivate dysfunctional p53. This vital malignant inhibitor protein is frequently disabled in various types of tumors, leading https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research